Overview

Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter

Status:
Completed

Trial end date:
2006-05-01

Target enrollment:

Participant gender:

Summary

Double blind study to evaluate the efficacy and tolerability of SSR149744C and select a dose to be further investigated in the maintenance of sinus rhythm after electrical, pharmacological or spontaneous conversion of AF/AFL.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Sanofi

Treatments:

Amiodarone